Omega-3 Fatty Acids and Cardiovascular Disease
Publisher: Agency for Healthcare Research and Quality 2016
Number of pages: 1252
There have been hundreds of observational studies and clinical trials conducted to evaluate the effect of omega-3 fatty acids (n-3 FA) on CV disease (CVD) and its risk factors and intermediate markers. The n-3 FA are a group of long-chain and very-long-chain polyunsaturated fatty acids (PUFA) that are substrates for the synthesis of eicosanoids and are important components of cell membranes that impact fluidity.
Home page url
Download or read it online for free here:
by National Institutes of Health - International Medical publishing
Clinical practice guidelines for hypertension for the busy primary care clinician. The report focuses on practical applications of the new evidence, including a revised treatment algorithm, drug tables, and convenient references.
- Agency for Healthcare Research and Quality
There are two generally accepted strategies for managing atrial fibrillation (AF): rate control and rhythm control. However, within each strategic approach there are a large number of potential pharmacological and nonpharmacological therapies...
by Euan Ashley, Josef Niebauer - Remedica Publishing
The book on physiologic and pathophysiologic mechanisms of cardiovascular disease, gives guidelines as to when refer to specialist colleagues and explains what the specialist is likely to do. Aimed at the hospital doctor, generalist or student.
- Royal College of Physicians
Angina is pain that typically occurs in the front of the chest and is brought on by physical exertion or emotional stress. It is the main symptomatic manifestation of myocardial ischaemia and is usually caused by obstructive coronary artery disease.